Malaria remains one of the most significant public health challenges in Nigeria, accounting for a substantial proportion of outpatient visits and hospital admissions annually. Understanding the role of modern antimalarial treatments is crucial for both healthcare providers and patients.
What is Artemisinin-based Combination Therapy (ACT)?
ACT combines an artemisinin derivative with a partner drug to provide rapid and effective treatment for uncomplicated Plasmodium falciparum malaria. The World Health Organization (WHO) recommends ACT as the first-line treatment for uncomplicated malaria in all endemic regions.
The artemisinin component rapidly reduces parasite numbers during the first three days of treatment, while the partner drug eliminates the remaining parasites, providing a complete cure and reducing the risk of drug resistance development.
Dihydroartemisinin-Piperaquine: A Proven Combination
Among the WHO-recommended ACT formulations, the combination of Dihydroartemisinin and Piperaquine has emerged as a highly effective option. This combination offers several advantages:
- High cure rates: Clinical studies consistently demonstrate cure rates exceeding 95% for uncomplicated P. falciparum malaria
- Simple dosing: A complete treatment course typically requires just 3 days of once-daily dosing
- Long-acting protection: Piperaquine's long half-life provides a period of post-treatment prophylaxis
- Good tolerability: Generally well-tolerated with a favorable safety profile
DIPAKSO: AKSO PHARMA's ACT Solution
AKSO PHARMA's DIPAKSO Tablets contain Dihydroartemisinin 40mg and Piperaquine 320mg, providing a complete 3-day treatment course in a convenient 9-tablet pack. Manufactured by FRONT PHARMACEUTICAL PLC to international quality standards, DIPAKSO represents AKSO PHARMA's commitment to fighting malaria in Nigeria.
Key Reminders for Patients
If you suspect you have malaria, always seek medical diagnosis through a rapid diagnostic test (RDT) or microscopy before starting treatment. Complete the full 3-day course even if you feel better after the first day. Incomplete treatment can lead to drug resistance and treatment failure.
